文献速递呼吸衰竭与机械通气儿科与产科急症重症综合管理与镇静镇痛

产科COVID-19患者的通气参数及分娩的影响:一项多中心前瞻性队列研究

Ventilatory Parameters in Obstetric Patients With COVID-19 and Impact of Delivery: A Multicenter Prospective Cohort Study.
PubMed 文献 · Chest · 2022-10-17
一句话结论产科COVID-19需高级通气支持者,分娩不改变通气参数(除PaO2/FiO2外),SOFA24是IMV唯一危险因素,BMI和合并症与母亲死亡独立相关。

这项前瞻性多中心队列纳入21个ICU的91例需高级通气支持的产科COVID-19患者,入住ICU时孕周29.2±4.9周,69%在ICU分娩。IMV启动时平台压24.3±4.5 cm H2O、驱动压12.5±3.3 cm H2O、静态顺应性中位31 mL/cm H2O、PaO2/FiO2中位142,与普通COVID-19ICU人群相似。分娩前后平台压、驱动压、静态顺应性无显著变化,仅PaO2/FiO2在分娩后24h升高(P=.022)。SOFA24是IMV唯一危险因素(OR 1.97);母亲死亡与BMI(OR 1.10)和合并症(OR 4.15)独立相关;胎儿/新生儿死亡与分娩孕周(OR 0.67)和SOFA24(OR 1.53)相关。

要点

  • 产科COVID-19需IMV者启动时平台压24.3±4.5 cm H2O、驱动压12.5±3.3 cm H2O、静态顺应性中位31 mL/cm H2O,肺力学与普通COVID-19 ICU人群相似。
  • 分娩前后(<2h、≤2h、24h)平台压、驱动压、静态顺应性均无显著变化(P=.59、.69、.058),仅PaO2/FiO2在分娩后24h升高(P=.022)。
  • SOFA24是IMV唯一危险因素(OR 1.97;95%CI 1.29-2.99;P=.001)。
  • 母亲死亡独立危险因素为BMI(OR 1.10;95%CI 1.006-1.204;P=.037)和合并症(OR 4.15;95%CI 1.212-14.20;P=.023)。
  • 胎儿/新生儿死亡危险因素为分娩孕周(OR 0.67;95%CI 0.52-0.86;P=.002)和SOFA24(OR 1.53;95%CI 1.13-2.08;P=.006)。

适用人群与场景

  • 妊娠期及产后COVID-19患者,需在ICU接受高级通气支持(IMV、HFNC或NIV)。

研究设计与关键结果

  • 前瞻性多中心队列研究,91例患者入住21个ICU,入住时孕周29.2±4.9周,63例(69%)在ICU分娩。
  • 最大通气支持:IMV 69例(76%),HFNC 20例(22%),NIV 2例(2%)。
  • IMV启动时呼吸参数:平台压24.3±4.5 cm H2O,驱动压12.5±3.3 cm H2O,静态顺应性中位31 mL/cm H2O(IQR 26-40),PaO2/FiO2中位142(IQR 110-176)。
  • 分娩前(<2h)、分娩后(≤2h)及分娩后24h参数:平台压25.6±6.6、24±6.7、24.6±5.2 cm H2O(P=.59);驱动压13.6±4.2、12.9±3.9、13±4.4 cm H2O(P=.69);静态顺应性中位28(IQR 22.5-39)、30(IQR 24.5-44)、30(IQR 24.5-44)mL/cm H2O(P=.058);PaO2/FiO2中位134(IQR 100-230)、168(IQR 136-185)、192(IQR 132-232.5)(P=.022)。
  • 引产原因:母亲因素43/71(60.5%),母亲及胎儿因素21/71(29.5%),胎儿因素7/71(9.9%);14例(22.2%)在ICU出院后继续妊娠。
  • 母亲死亡危险因素:BMI(OR 1.10;95%CI 1.006-1.204;P=.037)和合并症(OR 4.15;95%CI 1.212-14.20;P=.023)。
  • 胎儿/新生儿死亡危险因素:分娩孕周(OR 0.67;95%CI 0.52-0.86;P=.002)和SOFA24(OR 1.53;95%CI 1.13-2.08;P=.006)。

证据类型、等级与局限

  • 证据类型:前瞻性多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 产科COVID-19需有创通气的患者,肺力学与普通COVID-19 ICU人群相似,不应仅因妊娠采用不同的通气目标。
  • 分娩主要由母亲原因诱发,除PaO2/FiO2外不改变通气参数,作者认为分娩不能作为改善肺力学的治疗手段。
  • SOFA24可辅助识别需IMV及胎儿/新生儿死亡高风险患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Current evidence on obstetric patients requiring advanced ventilatory support and impact of delivery on ventilatory parameters is retrospective, scarce, and controversial.

RESEARCH QUESTION: What are the ventilatory parameters for obstetric patients with COVID-19 and how does delivery impact them? What are the risk factors for invasive mechanical ventilation (IMV) and for maternal, fetal, and neonatal mortality?

STUDY DESIGN AND METHODS: Prospective, multicenter, cohort study including pregnant and postpartum patients with COVID-19 requiring advanced ventilatory support in the ICU.

RESULTS: Ninety-one patients were admitted to 21 ICUs at 29.2 ± 4.9 weeks; 63 patients (69%) delivered in ICU. Maximal ventilatory support was as follows: IMV, 69 patients (76%); high-flow nasal cannula, 20 patients (22%); and noninvasive mechanical ventilation, 2 patients (2%). Sequential Organ Failure Assessment during the first 24 h (SOFA24) score was the only risk factor for IMV (OR, 1.97; 95% CI, 1.29-2.99; P = .001). Respiratory parameters at IMV onset for pregnant patients were: mean ± SD plateau pressure (PP), 24.3 ± 4.5 cm H2O; mean ± SD driving pressure (DP), 12.5 ± 3.3 cm H2O; median static compliance (SC), 31 mL/cm H2O (interquartile range [IQR], 26-40 mL/cm H2O); and median Pao2 to Fio2 ratio, 142 (IQR, 110-176). Respiratory parameters before (< 2 h) and after (≤ 2 h and 24 h) delivery were, respectively: mean ± SD PP, 25.6 ± 6.6 cm H2O, 24 ± 6.7 cm H2O, and 24.6 ± 5.2 cm H2O (P = .59); mean ± SD DP, 13.6 ± 4.2 cm H2O, 12.9 ± 3.9 cm H2O, and 13 ± 4.4 cm H2O (P = .69); median SC, 28 mL/cm H2O (IQR, 22.5-39 mL/cm H2O), 30 mL/cm H2O (IQR, 24.5-44 mL/cm H2O), and 30 mL/cm H2O (IQR, 24.5-44 mL/cm H2O; P = .058); and Pao2 to Fio2 ratio, 134 (IQR, 100-230), 168 (IQR, 136-185), and 192 (IQR, 132-232.5; P = .022). Reasons for induced delivery were as follows: maternal, 43 of 71 patients (60.5%); maternal and fetal, 21 of 71 patients (29.5%); and fetal, 7 of 71 patients (9.9%). Fourteen patients (22.2%) continued pregnancy after ICU discharge. Risk factors for maternal mortality were BMI (OR, 1.10; 95% CI, 1.006-1.204; P = .037) and comorbidities (OR, 4.15; 95% CI, 1.212-14.20; P = .023). Risk factors for fetal or neonatal mortality were gestational age at delivery (OR, 0.67; 95% CI, 0.52-0.86; P = .002) and SOFA24 score (OR, 1.53; 95% CI, 1.13-2.08; P = .006).

INTERPRETATION: Contrary to expectations, pregnant patient lung mechanics were similar to those of the general population with COVID-19 in the ICU. Delivery was induced mainly for maternal reasons, but did not change ventilatory parameters other than Pao2 to Fio2 ratio. SOFA24 score was the only risk factor for IMV. Maternal mortality was associated independently with BMI and comorbidities. Risk factors for fetal and neonatal mortality were SOFA24 score and gestational age at delivery.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Vasquez DN, Giannoni R, Salvatierra A, et al. Ventilatory Parameters in Obstetric Patients With COVID-19 and Impact of Delivery: A Multicenter Prospective Cohort Study. Chest. 2022. PMID: 36257474. doi:10.1016/j.chest.2022.10.010

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。